NEUVASQ BIOTECHNOLOGIES

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Emmanuel Lacroix",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Biotech Advantage SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-07-22",
      "evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale acte la fin du mandat d\u0027administrateur et d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de Biotech Advantage SRL, repr\u00E9sent\u00E9e par Monsieur Emmanuel Lacroix en tant que repr\u00E9sentant permanent, avec effet au 22 juillet 2025. L\u0027assembl\u00E9e g\u00E9n\u00E9rale les remercie pour leurs services et l\u0027ex\u00E9cution de leur ",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois Fontaine",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale acte la fin du mandat d\u0027administrateur de Monsieur Fran\u00E7ois Fontaine en tant qu\u0027administrateur de la Soci\u00E9t\u00E9."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Fran\u00E7ois Fontaine",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT (S.F.P.I.) SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "II est remplac\u00E9 par SOCIETE FEDERALE DE PARTICIPATIONS ET D\u0027INVESTISSEMENT (S.F.P.I.) SA, repr\u00E9sent\u00E9e par Monsieur Fran\u00E7ois Fontaine en tant que repr\u00E9sentant permanent."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-06-30",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-09-26",
    "filing_date": "2024-09-24",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2024-08-28",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "conversion_legal_form",
  "report_waiver": null,
  "restructuring": null,
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null
  },
  "summary_narrative": "Une exp\u00E9dition du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires a \u00E9t\u00E9 d\u00E9pos\u00E9e le 28 ao\u00FBt 2024 par la notaire Kim Lagae \u00E0 Bruxelles. L\u0027acte porte sur l\u0027\u00E9mission de droits de souscription et inclut les rapports du conseil d\u0027administration et du commissaire, conform\u00E9ment aux articles 7:155 et 7:180 du Code des soci\u00E9t\u00E9s et des associations.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1750,
      "currency": "EUR",
      "after_eur": 111000,
      "delta_eur": 1750,
      "before_eur": 109250,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-04-29",
      "evidence_quote": "Cet acte constate la r\u00E9alisation de l\u2019augmentation du capital ... \u00E0 concurrence de mille sept cent cinquante euros (1.750 EUR) ... Le capital est fix\u00E9 \u00E0 cent onze mille euros (111.000 EUR)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-04-04",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Christophe Pelzer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0762966663",
        "name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-01-01",
      "evidence_quote": "Suite \u00E0 la d\u00E9cision de BDO R\u00E9viseurs d\u0027Entreprises SRL, il a \u00E9t\u00E9 d\u00E9cid\u00E9 de nommer Monsieur Christophe Pelzer en tant que repr\u00E9sentant permanent \u00E0 partir de l\u0027exercice 2022, en remplacement de Madame No\u00EBlle Lucas, dans le cadre du mandat de commissaire de NEUVASQ BIOTECHNOLOGIES SA."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Richard Porter",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-08-08",
      "evidence_quote": "Monsieur Richard Porter [...]. Monsieur Porter est nomm\u00E9 [...] en tant qu\u0027administrateur ind\u00E9pendant disposant d\u0027une expertise dans le secteur clinique et pr\u00E9-clinique. Monsieur Porter est nomm\u00E9 avec effet \u00E0 compter du 8 ao\u00FBt 2022 pour une dur\u00E9e de quatre ans prenant fin \u00E0 l\u0027occasion de l\u0027assembl\u00E9e "
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Emmanuel Lacroix",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0787767583",
        "name": "Biotech Advantage SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-08-08",
      "evidence_quote": "les actionnaires ont convenu de nommer Biotech Advantage SRL, repr\u00E9sent\u00E9e par Monsieur Emmanuel Lacroix en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 [...]. Le mandat de Biotech Advantage SRL, repr\u00E9sent\u00E9e par Monsieur Emmanuel Lacroix prendra effet \u00E0 compter du 8 ao\u00FBt 2022 pour une dur\u00E9e de quatre ans pre"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Michel All\u00E9",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-06-15",
      "evidence_quote": "L\u0027Assembl\u00E9e G\u00E9n\u00E9rale prend note de la d\u00E9mission de Michel All\u00E9 avec effet \u00E0 la date de la pr\u00E9sente assembl\u00E9e."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Michel All\u00E9",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "GEMA SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-06-15",
      "evidence_quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale nomme administrateurs ind\u00E9pendants GEMA SRL (repr\u00E9sent\u00E9e par Michel All\u00E9) et Yves Ribeill pour un mandat de 6 ans avec effet \u00E0 la date de la pr\u00E9sente assembl\u00E9e."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yves Ribeill",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-06-15",
      "evidence_quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale nomme administrateurs ind\u00E9pendants GEMA SRL (repr\u00E9sent\u00E9e par Michel All\u00E9) et Yves Ribeill pour un mandat de 6 ans avec effet \u00E0 la date de la pr\u00E9sente assembl\u00E9e."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 100000,
      "currency": "EUR",
      "after_eur": 106000,
      "delta_eur": 100000,
      "before_eur": 6000,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-06-18",
      "evidence_quote": "Le capital de la soci\u00E9t\u00E9 s\u2019\u00E9l\u00E8ve d\u00E9sormais \u00E0 cent six mille euros (106.000 EUR) ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de cr\u00E9er une nouvelle classe d\u2019actions et d\u2019\u00E9mettre cinq mille (5.000) actions nouvelles de classe A en r\u00E9mun\u00E9ration d\u2019un apport suppl\u00E9mentaire en num\u00E9raire de cinq millions d\u2019euros (EUR 5.000.000,00) ... L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u2019affecter cet apport suppl\u00E9mentaire : \u00E0 concurrence de cent mille euros (100.000 EUR) \u00E0 un compte d\u2019apport indisponible",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Daniele Carati",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Les actionnaires d\u00E9cident de r\u00E9voquer le mandat d\u0027administrateur de la soci\u00E9t\u00E9 de Monsieur Daniele Carati, n\u00E9 \u00E0 Monceau-sur-Sambre, le 19 janvier 1966, domicill\u00E9 \u00E0 1050 Ixelles, Avenue G\u00E9n\u00E9ral M\u00E9decin Derache 80RC."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Didier Georges",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Les actionnaires d\u00E9cident de r\u00E9voquer le mandat d\u0027administrateur de la soci\u00E9t\u00E9 de Monsieur Didier Geroges, n\u00E9 \u00E0 Bruxelles, le 4 d\u00E9cembre 1968, domicili\u00E9 \u00E0 1401 Nivelles (Baulers), Rue Alz\u00E9mont 19."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lotfi Yelles",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0507740263",
        "name": "EEBIC ventures SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Les actionnaires d\u00E9cident de nommer, en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9, la soci\u00E9t\u00E9 EBBIC Ventures, soci\u00E9t\u00E9 anonyme de droit belge, dont le si\u00E8ge social est situ\u00E9 \u00E0 1070 Anderlecht, all\u00E9e de la Recherche 12 et inscrite au Registre des personnes morales (Bruxelles) sous le num\u00E9ro 0507.740.263,"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marie Bouillez",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0707902931",
        "name": "Theodorus IV SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Les actionnaires d\u00E9cident de nommer, en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9, la soci\u00E9t\u00E9 Theodorus IV, soci\u00E9t\u00E9 anonyme de droit belge, dont le si\u00E8ge social est situ\u00E9 \u00E0 1070 Anderlecht, all\u00E9e de la Recherche 12 et inscrite au Registre des personnes morales (Bruxelles) sous le num\u00E9ro 0707.902.931, a"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SRL"
  }
}

{
  "kind": "oprichting",
  "seat": "Rue Auguste Piccard 48, 6041 Gosselies",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1979-09-27",
        "name": "VANHOLLEBEKE Benoit Pieter Jean Fran\u00E7ois",
        "niss": null,
        "address": "1160 Auderghem, Avenue Isidore Geyskens 16"
      },
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 3600,
      "holder_person_name": "VANHOLLEBEKE Benoit Pieter Jean Fran\u00E7ois",
      "is_subscriber_only": false,
      "n_shares_subscribed": 3600,
      "amount_subscribed_eur": 3600,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0859.775.138",
        "name": "ULB DEV\u0027"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": "0859.775.138",
      "holder_org_name": "ULB DEV\u0027",
      "contribution_type": "cash",
      "amount_paid_in_eur": 2400,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 2400,
      "amount_subscribed_eur": 2400,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 6000,
  "subject_company": {
    "kbo": "0762.966.663",
    "name_full": "NEUVASQ BIOTECHNOLOGIES",
    "legal_form": "SRL"
  },
  "initial_directors": [],
  "incorporation_date": "2021-02-04",
  "post_incorporation_mandates": []
}